I am a fellowship trained Academic Urological Surgeon working in Glasgow, managing patients with prostate and bladder cancer as part of my practice. I am one of a handful of U.K. surgeons trained to perform surgery for prostate and bladder cancer using a Robotic (Da Vinci) platform.
After graduating from the University of Glasgow, I spend most of my training in the West of Scotland, where I was trained fully in open, laparoscopic and endoscopic surgery. To complete my training, I undertook a fellowship at one of Europe’s highest volume Robotic Uro-Oncology centres at University College London Hospital (UCLH) where I was fully trained to perform Robotic Radical Prostatectomies and Robotic Radical Cystectomies for the management of Prostate and Bladder Cancer respectively.
I have recently returned to Scotland as a Consultant, and am part of the team that has successfully set up, and trained members of the Robotic Pelvic Cancer Service in the West of Scotland.
Based at the Queen Elizabeth University Hospital (QEUH) in Glasgow, I am one of the highest volume Robotic Prostatectomists in the United Kingdom. As part of my NHS practice I also offer Radical Cystectomy for High Risk/Muscle Invasive Bladder Cancer.
At BMI Ross Hall I manage patients with benign and malignant disorders of the prostate and bladder. I offer the whole spectrum of management, from initial diagnosis, to treatment and subsequent follow-up. In addition, I offer treatment for inguino-scrotal disorders.
I am also currently a Clinical Senior Lecturer and CRUK Clinician Scientist in Uro-oncology at the CRUK: Beatson Institute and the Institute for Cancer Sciences at the University of Glasgow. I carried out my PhD (2007-2011) at the Beatson under the supervision of Professors Owen J Samson and Hing Y Leung, looking at the role of Wnt signalling in bladder cancer (funded by the MRC and CRUK). My current research interest is in understanding the mechanisms of treatment resistance in advanced prostate cancer. As part of the Urology Group at the Beatson, the work in my laboratory uses novel in vivo models in conjunction with patient samples to interrogate the disease processes in advanced and treatment resistant prostate cancer. This is funded by a £1.5 million Clinician Scientist Fellowship from CRUK, making me one of only 3 Urologists in the UK to currently hold such an award.